Eris Lifesciences Secures ANVISA Approval for Sterile Injectable Facility in Ahmedabad
Eris Lifesciences has received Anvisa approval for one of its sterile injectable manufacturing facilities in Ahmedabad, enabling entry into the Brazilian market.
Eris Lifesciences | 26/08/2025 | By Mrinmoy Dey
Eris Lifesciences Secures ANVISA Approval for its Manufacturing Unit in Ahmedabad
Eris Lifesciences has received ANVISA approval for a manufacturing unit at its Ahmedabad campus, paving the way for entry into Brazil, South America’s largest pharmaceutical market.
Eris Lifesciences | 25/08/2025 | By Mrinmoy Dey
Eris Lifesciences Announces Acquisition of Biocon Biologics
Eris Lifesciences Ltd. has recently acquired Biocon Biologics’ Branded Formulations business in India in a deal worth INR 1,242 crore.
Eris Lifesciences | 19/03/2024 | By Manvi | 388
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy